Safety and Pharmacokinetics of PATANASE in Paediatric Patients 2 to < 6 Years of Age with a history of allergic rhinitis

Trial Profile

Safety and Pharmacokinetics of PATANASE in Paediatric Patients 2 to < 6 Years of Age with a history of allergic rhinitis

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2017

At a glance

  • Drugs Olopatadine (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions
  • Sponsors Alcon
  • Most Recent Events

    • 02 Mar 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology
    • 05 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Dec 2009 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top